Kunyi Du
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Development and validation of a predictive model for overall survival in esophageal squamous cell carcinoma post-esophagectomy: the role of lymph node metastatic stations.
Journal: International journal of surgery (London, England)
Published: May 20, 2024
Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis.
Journal: BMJ open gastroenterology
Published: April 25, 2024
Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: November 09, 2023
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis.
Journal: Annals of surgical oncology
Published: November 06, 2023
Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma.
Journal: Frontiers in immunology
Published: October 12, 2023
Mapping of Lymph Node Metastasis and Efficacy Index in Thoracic Esophageal Squamous Cell Carcinoma: A Large-Scale Retrospective Analysis.
Journal: Annals of surgical oncology
Published: February 09, 2023
Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis.
Journal: Oncology letters
Published: December 20, 2022
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study.
Journal: International journal of surgery (London, England)
Published: November 01, 2022
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study.
Journal: Frontiers in immunology
Published: January 13, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026